Upexi's Q3 SOL holdings rise 9% to over 2M; Prenetics to sell 510 BTC for $40M; Sharps Technology acquires 95% of 2M SOL

iconKuCoinFlash
Share
Share IconShare IconShare IconShare IconShare IconShare IconCopy
AI summary iconSummary

expand icon
Today’s BTC news highlights significant shifts in crypto holdings. Upexi’s Q3 SOL holdings increased by 9% to over 2 million tokens. Prenetics Global plans to sell 510 BTC in a $40 million transaction, expected to complete by May 14. Sharps Technology staked 95% of its 2 million SOL, earning annualized returns of 7%. BTC update: institutional activity remains robust across multiple assets.

ME News report, May 13 (UTC+8): According to comprehensive disclosures from BBX crypto-related stock information, Upexi released its Q3 FY2026 financial report yesterday: SOL holdings increased by 9% quarter-over-quarter to over 2 million tokens; Prenetics Global is executing a liquidation plan for 510 BTC, aiming to complete it before May 14, with an expected revenue of approximately $40 million; over 95% of Sharps Technology’s more than 2 million SOL treasury holdings have been staked, yielding an annualized return of approximately 7%.

[Key Updates]

  • Upexi, Inc. (NASDAQ: UPXI) Q3 FY2026 Earnings Report: Revenue of $4.56 million (up 43.8% year-over-year, below expectations of $8.25 million), net loss of $109 million (including a non-cash, unrealized loss of $92.3 million on SOL holdings). During Q3, SOL holdings increased by approximately 189,000 tokens (+9%), reaching over 2 million SOL as of the reporting date, the vast majority of which are staked. The company completed a $36 million convertible bond private placement (backed by 265,500 locked SOL tokens) and a $7.4 million registered direct offering. Management expects operating cash outflows to be lower than staking income before July 2026, achieving cash flow neutrality; shares fell approximately 8% on the day.

  • The Board of Prenetics Global Limited (NASDAQ: PRE) approved on May 1 the full liquidation of approximately 510 BTC—accumulated at a rate of one BTC per day since August 1, 2025—executed via institutional over-the-counter channels, with completion targeted by May 14. Based on recent market prices of approximately $80,000 per BTC, the expected total proceeds are around $40 million. Upon completion of the liquidation, the company’s combined cash and liquid assets are projected to reach $145–150 million, with no interest-bearing debt. The proceeds will be used to expand the $40 million share repurchase program and to promote direct-to-consumer sales of the IM8 health brand. ⚠️ The BTC were sold at a loss, and the company has declared a permanent exit from its digital assets strategy.

Sharps Technology, Inc. (NASDAQ: STSS), according to the latest publicly available data, holds over 2 million SOL tokens, jointly custodied by BitGo and Coinbase Institutional, with approximately 95% staked through the Coinbase Institutional validation node (STSS Validator), generating an annual gross yield of about 7%. With SOL currently trading around $135–140, the company still holds a paper loss of approximately 30% compared to its average holding price of around $195. The company regularly discloses staking income data; in FY2025, it accumulated SOL through over $430 million in financing, and confirmed the continued execution of this strategy in its annual report released on April 6. (Source: BBX)

Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.